Rare lung cancer special: a multifaceted approach Andreas Pircher editorial 24 May 2024 Pages: 73 - 74
Antibody–drug conjugates (ADC special)—part 1 Simon Peter Gampenrieder editorial 24 May 2024 Pages: 75 - 76
The future of clinical trials—goals, ideas, and discussion Michael GnantManuela GiliHannes Fohler review Open access 18 April 2024 Pages: 77 - 86
Upper-GI highlights from ASCO and ASCO-GI 2023 meetings: changing paradigm in treatment sequence Aysegül Ilhan-MutluElisabeth Sophie Bergen short review Open access 29 December 2023 Pages: 87 - 91
Treatment-changing news in urogenital cancer—a brief unstructured narrative review based on findings presented at the ESMO 2023 conference Alexander Jakob ZgubicMarianne LeitsmannMartin Pichler short review Open access 18 March 2024 Pages: 92 - 95
ASCO 2023: highlights in breast cancer Rupert Bartsch short review Open access 05 December 2023 Pages: 96 - 99
Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma Changbin WangRan ZhangLigang Xing original report 28 February 2024 Pages: 100 - 106
Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report Nino Rafael MüserKlaus KirchbacherGeorg-Christian Funk case report 08 January 2024 Pages: 107 - 109
Pulmonary puzzles: salivary gland-type tumors of the lung and their metastatic equivalents Gheorghe-Emilian OlteanuLuka Brcic short review Open access 11 January 2024 Pages: 110 - 116
Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations Yana SharapovaSonja LogesMelanie Janning short review Open access 08 February 2024 Pages: 117 - 122
Diagnosis and management of mediastinal extragonadal germ cell tumors Axel HeidenreichPia PaffenholzDavid Pfister short review Open access 18 December 2023 Pages: 123 - 129
Antibody–drug conjugates in ovarian cancer Barin FerozChristian MarthAlain Gustave Zeimet short review Open access 25 January 2024 Pages: 130 - 134
Antibody–drug conjugates in the treatment of lymphoid neoplasms Peter NeumeisterKatharina Theresa Prochazka short review Open access 08 May 2024 Pages: 135 - 139
Brief update on systemic therapies in myeloproliferative neoplasms Janine SteichenDominik Wolf short review Open access 31 August 2023 Pages: 140 - 145
Prognostic factors of long-term survivors with unresectable pancreatic cancer: a retrospective analysis Giuseppe A. CollocaAntonella Venturino original report 17 October 2023 Pages: 146 - 151